← Open Payments lookup

JENNIFER LAZZARA: Open Payments

NPI 1720503881 · MURRAY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,572 in 63 payments from 27 companies in 2025. Trend: 2023 $4,042 · 2024 $3,299 · 2025 $1,572

Food & beverage: $1,572
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$191
Novartis Pharmaceuticals Corporation8$156
PFIZER INC.9$151
GENZYME CORPORATION1$150
Koya Medical, Inc.1$108
Myriad Genetic Laboratories, Inc.3$76
Merck Sharp & Dohme LLC3$71
Astellas Pharma US Inc3$69
Genentech USA, Inc.3$61
ARRAY BIOPHARMA INC2$47

Products named: SARCLISA, KOYA MEDICAL, KISQALI, KEYTRUDA, ENHERTU, IMFINZI, Vyloy, XALKORI.

Industry payments across UT — which companies pay providers there.